Outcomes of surgical management for borderline (BR)/locally advanced (LA) pancreatic adenocarcinoma (PAC) after neoadjuvant FOLFIRINOX chemotherapy: Results of an AGEO/French multicenter study.
Daniel Pietrasz
No relevant relationships to disclose
Lysiane Marthey
No relevant relationships to disclose
Mathilde Wagner
No relevant relationships to disclose
Jean-Frédéric Blanc
No relevant relationships to disclose
Eric Terrebonne
No relevant relationships to disclose
Antonio Sa Cunha
No relevant relationships to disclose
Romain Coriat
Consultant or Advisory Role - Keocyt; Novartis; Roche
Isabelle Trouilloud
No relevant relationships to disclose
Nicolas Regenet
No relevant relationships to disclose
Pascal Artru
Consultant or Advisory Role - Amgen; Merck Serono; Roche; Sanofi
Honoraria - Amgen; Merck Serono; Roche; Sanofi
Eric Francois
No relevant relationships to disclose
Lilian Schwarz
No relevant relationships to disclose
David Malka
No relevant relationships to disclose
Jean-Christophe Vaillant
No relevant relationships to disclose
Jean Baptiste Bachet
Consultant or Advisory Role - Amgen; Celgene; Roche; Sanofi
Honoraria - Bayer; Lilly; Merck Serono; Novartis
Mehdi Karoui
No relevant relationships to disclose